NBP - SEC Form 4 insider transactions

SEC Form 4 filed by Chief Commercial Officer Hagler Mark Arnold

SEC Form 4 filed by General Counsel Lin Liwei Lorraine

SEC Form 4 filed by Chief Executive Officer Gupta Srishti

SVP, Clinical Development Xu Cong Claire converted options into 12,432 units of Ordinary Shares and sold $3,992 worth of Ordinary Shares (4,485 units at $0.89), increasing direct ownership by 3% to 298,101 units (SEC Form 4)

SEC Form 4 filed by Director Fu Wei

SEC Form 4 filed by Chief Bus. Development Officer Cao Sean Wuxiong

Chief Medical Officer Dennis Phillip Andrew converted options into 23,695 units of Ordinary Shares and sold $5,606 worth of Ordinary Shares (8,494 units at $0.66), increasing direct ownership by 11% to 157,941 units (SEC Form 4)

SVP, Clinical Development Xu Cong Claire converted options into 9,382 units of Ordinary Shares and sold $13,766 worth of Ordinary Shares (3,494 units at $3.94), increasing direct ownership by 2% to 290,154 units (SEC Form 4)

Officer Cao Sean Wuxiong sold $42,584 worth of Ordinary Shares (21,399 units at $1.99), decreasing direct ownership by 38% to 35,073 units (SEC Form 4) to cover taxes